Date: 28th May 2014
An Urgent Need for Validating and Characterizing Antibodies
Our panel of experts will be able to offer advice on what can be done to help solve common problems associated with antibody use, as well as, what should be done as a community to address this issue at large.
Wednesday May 28, 2014 2:30 – 4:00 p.m. Eastern Time
Antibodies are among the most common reagents used in both research and clinical laboratories. Yet, there are no standard guidelines in place when it comes to manufacturing, validating, and using antibodies. Antibodies are often found to be not as specific, selective or reproducible as they are claimed to be and researchers still continue to take these claims at face value, without understanding or addressing the need to have antibodies validated for their specific use. This free, educational webinar provides an opportunity for a global audience to get-together, as a part of a live forum, to share their experiences and concerns. Our panel of experts will be able to offer advice on what can be done to help solve common problems associated with antibody use, as well as, what should be done as a community to address this issue at large. Topics to be covered: • The pitfalls of working with antibodies • What constitutes a good antibody • Antibody validation methods • Use of proper controls • Need for more stringent guidelines and minimum standards Speakers: Dr. C. Glenn Begley Chief Scientific Officer and Senior Vice President Research & Development TetraLogic Pharmaceuticals Dr. David L. Rimm Professor Departments of Pathology and Medicine Yale University School of Medicine Dr. Anita Bandrowski Center for Research in Biological Systems University of California, San Diego Project Lead Neuroscience Information Framework
Event host: Bethyl